Evaluation and testing services (ETS) for vaccines and other biologics for infectious diseases.
Active Indefinite Delivery Contract Awarded
- Contract number
- 75N93025D00031
- Awardee
-
Bioqual, Inc. UEI CK9LGQ7EBNN8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Evaluation and testing services (ETS) for vaccines Solicitation · Posted Jun 21, 2024
- Last date to order 11% complete
- IDV ceiling
- $136,588,701.00
- Maximum order
- $136,588,701.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 26 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Bioqual, Inc., a for-profit biomedical research services company located in Rockville, Maryland. The $136.6 million single-award IDC has an ultimate completion date of September 29, 2035 and will provide evaluation and testing services (ETS) for vaccines and other biologics for infectious diseases.
Bioqual, an experienced federal contractor, will deliver a broad range of research services under this IDC, including conducting small animal models, non-human primate models, animal replacement models, and specialized reagent generation to support NIAID's work in developing countermeasures against infectious diseases. This contract builds on Bioqual's existing portfolio of IDCs with NIAID, including a $146.3 million IDC focused on animal model development and a $545 million multiple-award IDIQ contract supporting NIAID's comprehensive and rapid response research programs across clinical trials, manufacturing, nonclinical studies, analytics, and regulatory affairs.
Quick answers
Who was awarded contract 75N93025D00031?
75N93025D00031 was awarded to Bioqual, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2025.
How much is contract 75N93025D00031 worth?
75N93025D00031's own ceiling is $136,588,701. A single order can be worth up to $136,588,701.
Who can order from contract 75N93025D00031?
75N93025D00031 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N93025D00031 competed?
The extent of competition for 75N93025D00031 was full and open competition. The government received 26 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV